Finnish team of researchers finds a mutation in a tumour of the jaw
4/25/2014
A Finnish team of researchers was the first in the world to discover a gene mutation in ameloblastoma, which is a tumour of the jaw.
The European Head and Neck Cancer Society (EHNS) has released new recommendations for the best practice management of psycho-oncologic aspects of head and neck cancer.
Study identifies enzymes that help fix cancer-causing DNA defects
4/25/2014
Purdue University researchers have identified an important enzyme pathway that helps prevent new cells from receiving too many or too few chromosomes, a condition that has been directly linked to...
Gene can predict the prognosis of patients with breast cancer and their response to treatment
4/25/2014
Scientists have identified a gene which, when expressed in breast cancer, can help to predict a patient's chance of recovery and their likely response to therapy - and which they believe could be a...
Gold nanoparticles help target, quantify breast cancer gene segments in a living cell
4/25/2014
Purdue University researchers have developed a way to detect and measure cancer levels in a living cell by using tiny gold particles with tails of synthetic DNA.
UH biomedical engineer works to make blood transfusions safer
4/25/2014
A biomedical engineer at the University of Houston (UH) is working to develop highly innovative technology to make blood transfusions safer. His work is supported by a $1.
BET bromodomain inhibitors look promising for castration-resistant prostate cancer
4/25/2014
Prostate cancer becomes deadly when anti-hormone treatments stop working. Now a new study suggests a way to block the hormones at their entrance.
Aspirin can reduce colorectal cancer risks for those with specific gene
4/25/2014
The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high...
FDA approves Sylvant for multicentric Castleman's disease
4/25/2014
The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat patients with multicentric Castleman's disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph...
Cloaked DNA nanodevices survive pilot mission
4/25/2014
It's a familiar trope in science fiction: In enemy territory, activate your cloaking device. And real-world viruses use similar tactics to make themselves invisible to the immune system.